ARCHIVES

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

This article is from The Cancer Letter archive.

Vol. 28 No. 44 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Regular NSAIDs Use Protects Smokers From Lung Cancer

March 28, 2003

In Brief: Georgetown, Theurer Form Collaboration; Hopkins To Develop Bladder Cancer Institute

June 6, 2014

Duke Deans Acknowledge Withholding Key Document From Outside Reviewers

January 14, 2011

President Drops Revision Plan; NCI To Receive $937.1 Million Voted By Congress For FY 1979

January 12, 1979

GAO Decision Clears NCI to Deploy Medidata Rave Data Capture System

June 17, 2011

New Abiraterone Acetate Results Show Greater Benefit Than Before

June 24, 2011